急性缺血性卒中的神经保护药物研究进展

中国临床药理学与治疗学 ›› 2005, Vol. 10 ›› Issue (8): 841-845.

• 综述 • 下一篇

急性缺血性卒中的神经保护药物研究进展

俞月萍, 徐秋琴¹, 魏尔清²

浙江医学高等专科学校药理学教研室, 杭州 310053, 浙江;
¹杭州师范学院医学院药理学教研室, 杭州 310012, 浙江;
²浙江大学医学院药理学教研室, 杭州 310031, 浙江

收稿日期:2005-06-14 修回日期:2005-07-19 发布日期:2020-11-22
通讯作者: 俞月萍,女,硕士,副教授,研究方向:神经药理学。Tel:0571-87692673 E-mail:yueping@mail.hz.zj.cn
基金资助:
浙江省科技计划项目(No2002C33056)和浙江省医药卫生科研基金项目(No2002B014)

Recent progress in research of neuroprotective drugs on acute ischemic stroke

YU Yue-ping, XU Qiu-qin¹, WEI Er-qing²

Department of Pharmacology, Zhejiang Medical College, Hangzhou 310053, Zhejiang, China;
¹Department of Pharmacology, School of Medical, Hangzhou Teachers College, Hangzhou 310012, Zhejiang, China;
²Department of Pharmacology, School of Medicine, Zhejiang University, Hangzhou 310031, Zhejiang, China

Received:2005-06-14 Revised:2005-07-19 Published:2020-11-22

摘要/Abstract

摘要： 缺血性脑损伤的病理生理机制包括兴奋性氨基酸的释放、梗死灶周围去极化、炎症反应及神经元凋亡等。几乎对缺血级联反应的所有环节都已进行过神经保护药物的开发和试验。许多神经保护药物在脑缺血动物模型研究中证明有效,但临床试验效果却难以令人满意。本文就目前各类神经保护药治疗脑缺血的临床前期和临床试验的结果与进展作简要的回顾和展望。

关键词: 缺血性卒中, 脑缺血, 脑梗死, 神经保护, 研究进展

Abstract: The pathophysiological mechanisms of ischemic cerebral injury involved in the release of excitatory amino acids, depolarization about the infarction, inflammatory reaction and neuron apoptosis.The development and trial of neuroprotective drugs have almost been launched in all links of ischemic cascade reaction.Many neuroprotective drugs were proved to be effective for cerebral ischemia in animal models, but they were not proved on clinical trials.The results and progresses of the preclinical phase and clinical application of various kinds of neuroprotective drugs on the cerebral ischemia were reviewed in this paper and the prospective uses of these drugs were also introduced.

Key words: ischemic stroke, cerebral ischemia, cerebral infarction, neuroprotection, recent progress in research

中图分类号:

R743.31

俞月萍, 徐秋琴, 魏尔清. 急性缺血性卒中的神经保护药物研究进展[J]. 中国临床药理学与治疗学, 2005, 10(8): 841-845.

YU Yue-ping, XU Qiu-qin, WEI Er-qing. Recent progress in research of neuroprotective drugs on acute ischemic stroke[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(8): 841-845.

参考文献

1 Bonita R.Stroke prevention:a global perspective[A].In: Norris JW, Hachinski V, eds.Stroke prevention[M].New York, NY:Oxford University Press, 2001:259-74
2 Sarhan S, Wettstein JG, Maynard KI.Delayed treatment with 5-nitro-6, 7-dichloro-1, 4-dihydro-2, 3-quinoxalinedione, a glycine site N-methyl-D-aspartate antagonist, protects against permanent middle cerebral artery occlusion in male rats[J]. Neurosci Lett, 2003;347:147-50
3 Hoyte L, Barber PA, Buchan AM, Hill MD.The rise and fall of NMDA antagonists for ischemic stroke[J].Curr Mol Med, 2004;4:131-6
4 Akins PT, Atkinson RP.Glutamate AMPA receptor antagonist treatment for ischaemic stroke[J].Curr Med Res Opin, 2002; 18:S9-13
5 Kawasaki-Yatsugi S, Ichiki C, Yatsugi S, TakahashiM, Shimizu-Sasamata M, Yamaguchi T, et al.Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model[J].Neuropharmacology, 2000; 39:211-7
6 Koinig H, Vornik V, Rueda C, Zornow MH.Lubeluzole inhibits accumulation of extracellular glutamate in the hippocampus during transient global cerebral ischemia[J].Brain Res, 2001; 898:297-302
7 Mueller RN, Deyo DJ, Brantley DR, Disterhoft JF, Zornow MH.Lubeluzole and conditioned learning after cerebral ischemia[J].Exp Brain Res, 2003;152:329-34
8 Koinig H, Morimoto Y, Zornow MH.The combination of lamotrigine and mild hypothermia prevents ischemia-induced increase in hippocampal glutamate[J].J Neurosurg Anesthesiol, 2001;13:106-12
9 Caputi L, Hainsworth AH, Lavaroni F, LeachMJ, McNaughton NC, Mercuri NB, et al.Neuroprotective actions in vivo and electrophysiological actions in vitro of 202W92[J].Brain Res, 2001;919:259-68
10 Liu C, Zhou R, Sun S.Nimodipine modulates Bcl-2 and Bax mRNA expression after cerebral ischemia[J].J Huazhong Univ Sci Technolog Med Sci, 2004;24:170-2
11 Iwasaki K, Mishima K, Egashira N, Al-Khatib IH, Ishibashi D, Irie K, et al.Effect of nilvadipine on the cerebral ischemiainduced impairment of spatial memory and hippocampal apoptosis in rats[J].J Pharmacol Sci, 2003;93:188-96
12 Adachi N, Lei B, Soutani M, Arai T.Different roles of neuronal and endothelial nitric oxide synthases on ischemic nitric oxide production in gerbil striatum[J].Neurosci Lett, 2000;288: 151-4
13 Jiang MH, Kaku T, Hada J, Hayashi Y.Different effects of eNOS and nNOS inhibition on transient forebrain ischemia[J]. Brain Res, 2002;946:139-47
14 Gursoy-Ozdemir Y, Bolay H, Saribas O, Dalkara T.Role of endothelial nitric oxide generation and peroxynitrite formation in reperfusion injury after focal cerebral ischemia [J].Stroke, 2000;31:1974-80
15 Imai H, Graham DI, Masayasu H, Macrae IM.Antioxidant ebselen reduces oxidative damage in focal cerebral ischemia[J].Free Radic BiolMed, 2003;34:56-63
16 Nito C, Kamiya T, Amemiya S, Katoh K, Katayama Y.The neuroprotective effect of a free radical scavenger and mild hypothermia following transient focal ischemia in rats[J].Acta Neurochir Suppl, 2003;86:199-203
17 Lee H, Bae JH, Lee SR.Protective effect of green tea polyphenol EGGE against neuronal damage and brain edema after unilateral cerebral ischemia in gerbils[J].J Neurosci Res, 2004;77:892-900
18 Simi A, Porsmyr-Palmertz M, Hjerten A, Ingelman-Sundberg M, Tindberg N.The neuroprotective agents chlomethiazole and SB203580 inhibit IL-1 beta signalling but not its biosynthesis in rat cortical glial cells[J].J Neurochem, 2002;83:727-37
19 Zhang RL, ChoppM, Jiang N, Tang WX, Prostak J, Manning AM, et al.Anti-intercellular adhesion molecule-1 antibody reduces ischemic cell damage after transient but not permanent middle cerebral artery occlusion in the Wistar rat[J].Stroke, 1995;26:1438-42
20 Enlimomab Acute Stroke Trial Investigators.Use of anti-ICAM-1 therapy in ischemic stroke:results of the enlimomab acute stroke trial[J].Neurology, 2001;57:1428-34
21 Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA.Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat[J].Br J Pharmacol, 2003;140:471-6
22 Zaremba J, Skrobanski P, Losy J.Tumour necrosis factor-αis increased in the cerebrospinal fluid and serum of ischemic stroke patients and correlates with the volume of evolving brain infarct[J].Biomed Pharmacother, 2001;55:258-63
23 Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al.Tumor necrosis factor-α.A mediator of focal ischemic brain injury[J].Stroke, 1997;28:1233-44
24 Nawashiro H, Martin D, Hallenbeck JM.Neuroprotective effects of TNF binding protein in focal cerebral ischemia[J]. Brain Res, 1997;778:265-71
25 Wang X, Feuerstein GZ, Xu L, Wang H, Schumacher WA, Ogletree ML, et al.Inhibition of tumor necrosis factor-alpha-Chin J Clin Pharmacol Ther converting enzyme by a selective antagonist protects brain from focal ischemic injury in rats[J].Mol Pharmacol, 2004;65:890-6
26 Yin W, Badr AE, Mychaskiw G, Zhang JH.Down regulation of COX-2 is involved in hyperbaric oxygen treatment in a rat transient focal cerebral ischemia model[J].Brain Res, 2002; 926:165-71
27 Candelario-Jalil E, Alvarez D, Castaneda JM, Al-Dalain SM, Martinez-Sanchez G, Merino N, et al.The highly selective cyclooxygenase-2 inhibitor DFU is neuroprotective when given several hours after transient cerebral ischemia in gerbils[J].Brain Res, 2002;927:212-5
28 Ciceri P, Rabuffetti M, Monopoli A, Nicosia S.Production of leukotrienes in a model of focal cerebral ischemia in the rat[J]. Br J Pharmacol, 2001;133:1323-9
29 Joly LM, Mucignat V, Mariani J, Plotkine M, Charriaut-Marlangue C.Caspase inhibition after neonatal ischemia in the rat brain[J].J Cereb Blood Flow Metab, 2004;24:124-31

[1]	王金刚, 李强, 孙会艳, 王洪权. 鼠尾草酸在帕金森病中的神经保护作用机制研究进展[J]. 中国临床药理学与治疗学, 2023, 28(9): 1073-1080.
[2]	罗师萍, 张捷, 俞育帅, 宋传贵. HER2阳性乳腺癌的靶向治疗进展[J]. 中国临床药理学与治疗学, 2023, 28(8): 876-886.
[3]	王坤, 许佩佩, 周兰兰, 鲁晟. 人参皂苷Rg1调控Epac1/Rap1信号通路对缺血性脑卒中大鼠神经保护作用机制研究[J]. 中国临床药理学与治疗学, 2023, 28(7): 721-727.
[4]	吴志勇, 刘兵荣, 李彬, 汤睿. 红细胞分布宽度对急性缺血性卒中静脉溶栓早期神经功能改善不良的预测作用[J]. 中国临床药理学与治疗学, 2023, 28(3): 307-314.
[5]	张莉, 蔺兴遥, 尚芸, 王强. 冻伤的病理机制及治疗研究进展[J]. 中国临床药理学与治疗学, 2023, 28(3): 347-354.
[6]	李晨豪, 喻喜华, 闫文浩, 柴宇霞, 李燕燕, 李锟, 李泽运. 儿童癫痫与维生素D相关性研究进展[J]. 中国临床药理学与治疗学, 2023, 28(11): 1299-1306.
[7]	刘丹, 刘明, 金良友, 潘娟, 辛昊儒, 刘梦圆, 李鑫, 郑坤, 冯晓灵. 木香烃内酯抗肿瘤活性研究进展[J]. 中国临床药理学与治疗学, 2023, 28(10): 1168-1176.
[8]	李苗, 俞沁玮, 江振洲, 张陆勇. LDLR的调控机制及其相关疾病与药物研究进展[J]. 中国临床药理学与治疗学, 2022, 27(8): 946-954.
[9]	梁美芳, 陈庆状, 杨沛群, 王勇. 基于真实世界的阿托伐他汀仿制药和原研药防治缺血性脑卒中/短暂性脑缺血发作的有效性和安全性比较[J]. 中国临床药理学与治疗学, 2022, 27(7): 785-792.
[10]	曾晓凡, 许宜琪, 刘书, 吴茜, 李自保, 何俊俊, 金岳龙, 赵永莉, 何春玲, 高家林. 回顾性分析小剂量阿司匹林对2型糖尿病病人非致死性心梗和脑梗一级预防的作用[J]. 中国临床药理学与治疗学, 2022, 27(6): 665-671.
[11]	邓颖, 白殊同. 金圣草黄素相关药理作用机制的研究进展 [J]. 中国临床药理学与治疗学, 2022, 27(10): 1155-1162.
[12]	陈文捷, 王亚兵, 陈晓琳, 任俊玲, 赵晚君, 陈斌. 碘难治性分化型甲状腺癌的最新研究进展[J]. 中国临床药理学与治疗学, 2022, 27(1): 116-120.
[13]	郝海平. 我国代谢调控与药物靶标发现研究的进展与展望[J]. 中国临床药理学与治疗学, 2021, 26(8): 955-963.
[14]	陈颖, 袁勇贵. 中药单体、药对、复方、中成药治疗抑郁症研究进展[J]. 中国临床药理学与治疗学, 2021, 26(5): 586-593.
[15]	裴清华, 孙建立. 奥希替尼获得性耐药的研究进展[J]. 中国临床药理学与治疗学, 2021, 26(1): 105-112.

急性缺血性卒中的神经保护药物研究进展

Recent progress in research of neuroprotective drugs on acute ischemic stroke

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价